What Jim Cramer Expects From Valeant Pharmaceuticals' Results on Tuesday
TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer is keeping an eye on quarterly results from Valeant Pharmaceuticals on Tuesday.
TheStreet'sAction Alerts PLUS Charitable TrustManager Jim Cramer is keeping an eye on quarterly results from Valeant Pharmaceuticals (VRX) Tuesday.
Allergan (AGN) - Get Report is his favorite pharma stock for Action Alerts PLUS. Cramer also likes Merck (MRK) - Get Report , Eli Lilly (LLY) - Get Report and Johnson & Johnson (JNJ) - Get Report .
